Es gab 50 kürzliche Insider-Transaktionen für Blueprint Medicines Corporation (BPMC), darunter 18 Käufe und 32 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $78.81M und die gesamten Insider-Verkäufe auf $8.99M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Borisy Alexis, Seely Lynn, Beckman Daniella. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — BPMC
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2025-06-18 |
Borisy Alexis |
Director |
RSU-Zuteilung |
3,902 |
$128.12 |
$499.92K |
78,062 |
| 2025-06-18 |
Seely Lynn |
Director |
RSU-Zuteilung |
3,902 |
$128.12 |
$499.92K |
17,156 |
| 2025-06-18 |
Beckman Daniella |
Director |
RSU-Zuteilung |
3,902 |
$128.12 |
$499.92K |
14,744 |
| 2025-06-18 |
Goldberg Mark Alan |
Director |
RSU-Zuteilung |
3,902 |
$128.12 |
$499.92K |
22,156 |
| 2025-06-18 |
Coats Lonnel |
Director |
RSU-Zuteilung |
3,902 |
$12,812.00 |
$49.99M |
6,144 |
| 2025-06-18 |
Albers Jeffrey W. |
Director |
RSU-Zuteilung |
3,902 |
$128.12 |
$499.92K |
150,532 |
| 2025-06-18 |
Dable Habib J |
Director |
RSU-Zuteilung |
3,902 |
$128.12 |
$499.92K |
12,644 |
| 2025-06-18 |
Tsai John |
Director |
RSU-Zuteilung |
3,902 |
$128.12 |
$499.92K |
12,644 |
| 2025-06-03 |
Carter Percy H. |
Chief Scientific Officer |
Informierter Verkauf |
2,418 |
$127.88 |
$309.21K |
54,206 |
| 2025-05-27 |
Albers Jeffrey W. |
Director |
Optionsausübung (Verkauf) |
5,000 |
$36.05 |
$180.25K |
92,500 |
| 2025-05-19 |
Rossi Christina |
Chief Operating Officer |
Informierter Verkauf |
57 |
$101.72 |
$5.8K |
64,718 |
| 2025-05-05 |
Rossi Christina |
Chief Operating Officer |
Informierter Verkauf |
144 |
$103.56 |
$14.91K |
66,992 |
| 2025-05-05 |
Hurley Ariel |
Principal Accounting Officer |
Optionsausübung (Verkauf) |
2,752 |
$54.13 |
$148.97K |
2,751 |
| 2025-04-01 |
Haviland Kate |
Chief Executive Officer |
Informierter Verkauf |
100 |
$88.59 |
$8.86K |
165,929 |
| 2025-03-24 |
Rossi Christina |
Chief Operating Officer |
Informierter Verkauf |
2,274 |
$95.02 |
$216.08K |
69,266 |
| 2025-03-12 |
Albers Jeffrey W. |
Director |
Optionsausübung (Verkauf) |
7,500 |
$36.05 |
$270.38K |
97,500 |
| 2025-03-06 |
Hewes L. Becker |
Chief Medical Officer |
Informierter Verkauf |
2,541 |
$87.98 |
$223.56K |
30,419 |
| 2025-03-05 |
Landsittel Michael |
Chief Financial Officer |
Informierter Verkauf |
5,284 |
$88.80 |
$469.22K |
72,924 |
| 2025-03-05 |
Haviland Kate |
Chief Executive Officer |
Informierter Verkauf |
16,151 |
$88.80 |
$1.43M |
168,427 |
| 2025-03-05 |
Mccain Tracey L |
EVP and Chief Legal Officer |
Informierter Verkauf |
5,262 |
$88.80 |
$467.27K |
66,583 |
| 2025-03-05 |
Rossi Christina |
Chief Operating Officer |
Informierter Verkauf |
6,495 |
$88.80 |
$576.76K |
71,540 |
| 2025-03-05 |
Hurley Ariel |
Principal Accounting Officer |
Informierter Verkauf |
1,326 |
$88.80 |
$117.75K |
16,944 |
| 2025-03-05 |
Durso-bumpus Debra |
Chief People Officer |
Informierter Verkauf |
5,157 |
$88.80 |
$457.94K |
49,606 |
| 2025-03-05 |
Namouni Fouad |
President, R & D |
Informierter Verkauf |
6,489 |
$88.80 |
$576.22K |
75,781 |
| 2025-03-05 |
Hewes L. Becker |
Chief Medical Officer |
Informierter Verkauf |
4,863 |
$88.80 |
$431.83K |
35,651 |
| 2025-03-05 |
Lee Philina |
Chief Commercial Officer |
Informierter Verkauf |
3,733 |
$88.80 |
$331.49K |
41,996 |
| 2025-03-05 |
Carter Percy H. |
Chief Scientific Officer |
Informierter Verkauf |
3,530 |
$88.80 |
$313.46K |
56,865 |
| 2025-03-05 |
Albers Jeffrey W. |
Director |
Informierter Verkauf |
5,766 |
$88.80 |
$512.02K |
146,630 |
| 2025-03-03 |
Hurley Ariel |
Principal Accounting Officer |
Informierter Verkauf |
1,075 |
$95.16 |
$102.3K |
18,270 |
| 2025-03-01 |
Landsittel Michael |
Chief Financial Officer |
RSU-Zuteilung |
22,000 |
$96.57 |
$2.12M |
22,000 |
| 2025-03-01 |
Haviland Kate |
Chief Executive Officer |
RSU-Zuteilung |
70,400 |
$96.57 |
$6.8M |
70,400 |
| 2025-03-01 |
Mccain Tracey L |
EVP and Chief Legal Officer |
RSU-Zuteilung |
22,000 |
$96.57 |
$2.12M |
22,000 |
| 2025-03-01 |
Rossi Christina |
Chief Operating Officer |
RSU-Zuteilung |
26,400 |
$96.57 |
$2.55M |
26,400 |
| 2025-03-01 |
Hurley Ariel |
Principal Accounting Officer |
RSU-Zuteilung |
7,007 |
$96.57 |
$676.67K |
7,007 |
| 2025-03-01 |
Durso-bumpus Debra |
Chief People Officer |
RSU-Zuteilung |
22,000 |
$96.57 |
$2.12M |
22,000 |
| 2025-03-01 |
Namouni Fouad |
President, R & D |
RSU-Zuteilung |
26,400 |
$96.57 |
$2.55M |
26,400 |
| 2025-03-01 |
Hewes L. Becker |
Chief Medical Officer |
RSU-Zuteilung |
22,000 |
$96.57 |
$2.12M |
22,000 |
| 2025-03-01 |
Lee Philina |
Chief Commercial Officer |
RSU-Zuteilung |
22,000 |
$96.57 |
$2.12M |
22,000 |
| 2025-03-01 |
Carter Percy H. |
Chief Scientific Officer |
RSU-Zuteilung |
22,000 |
$96.57 |
$2.12M |
22,000 |
| 2025-02-20 |
Rossi Christina |
Chief Operating Officer |
Informierter Verkauf |
2,274 |
$95.14 |
$216.35K |
64,835 |
| 2025-01-21 |
Albers Jeffrey W. |
Director |
Optionsausübung (Verkauf) |
10,000 |
$36.05 |
$360.5K |
105,000 |
| 2025-01-21 |
Haviland Kate |
Chief Executive Officer |
Informierter Verkauf |
1,446 |
$110.24 |
$159.41K |
149,378 |
| 2025-01-21 |
Rossi Christina |
Chief Operating Officer |
Informierter Verkauf |
121 |
$111.81 |
$13.53K |
67,109 |
| 2025-01-13 |
Albers Jeffrey W. |
Director |
Optionsausübung (Verkauf) |
5,000 |
$36.05 |
$180.25K |
115,000 |
| 2025-01-13 |
Hurley Ariel |
Principal Accounting Officer |
Optionsausübung (Verkauf) |
2,250 |
$36.05 |
$81.11K |
2,250 |
| 2024-12-19 |
Albers Jeffrey W. |
Director |
Optionsausübung (Verkauf) |
15,000 |
$36.05 |
$540.75K |
120,000 |
| 2024-12-18 |
Rossi Christina |
Chief Operating Officer |
Informierter Verkauf |
108 |
$96.50 |
$10.42K |
69,383 |
| 2024-12-12 |
Hurley Ariel |
Principal Accounting Officer |
Optionsausübung (Verkauf) |
1,600 |
$15.01 |
$24.02K |
- |
| 2024-11-29 |
Haviland Kate |
Chief Executive Officer |
Informierter Verkauf |
207 |
$97.76 |
$20.24K |
150,824 |
| 2024-11-27 |
Rossi Christina |
Chief Operating Officer |
Informierter Verkauf |
2,274 |
$95.10 |
$216.26K |
71,657 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
